Publication | Open Access

Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study

Microrna-based SignatureEpithelial Ovarian CancerMedicineGynecologyPathologyCancer GenomicsEarly RelapseCancer GeneticsMicrorna DetectionOncologyTumor MicroenvironmentTumor BiologyOvarian Cancer